chronic GVHD when transferred to heavily irradiated allogeneic recipients . Significantly, GVHD did not occur when the marrow cells were depleted of mature T cells with anti-Thy 1 .2 antiserum and complement .
Materials and Methods
Mice. CBA/J, B lO.BR/SgSn , C3H/HeJ, CBA/H-T6J, and AKR/J (all H-2 k ) and C57BL/ 6J (B6), C57BL/IOJ (B10) and 129/J (all H-28 ) were obtained from The Jackson Laboratory, Bar Harbor, Maine . B IO.K (H-2 k ) mice were a gift from W . L. Elkins, University of Pennsylvania . (B6 X CBA/J)Fl mice were purchased from Cumberland View Farms, Clinton, Tenn. (BIO X B10 .BR)Fl and (C3H/He X BALB/c (H-2 d ))Fi mice were bred in our colony . Unless stated otherwise, male mice were used as donors and recipients . Mice 2-4 mo old were used as irradiated recipients of marrow cells after being maintained on a conventional diet and acid water ad libitum .
Media. RPMI-1640 (Microbiological Associates, Walkersville, Md .) supplemented with 10% fetal calf serum was used .
Injections. Cell suspensions were given intravenously in 0 .5 ml via the tail vein . Viability. Cell viability was assessed by dye exclusion . Cells. Bone marrow cells were obtained from tibia and femura by gentle flushing with cold medium via a 25 gauge needle . Clumps were removed by passage over sterile cotton filters and the cells were washed three times by centrifugation before final resuspension . Spleen and lymph node (LN) cells were obtained by mincing the organs with curved scissors over an 80-mesh stainless steel sieve in cold medium. T-cell-enriched populations of LN cells were obtained by passage through nylon wool columns as described by Julius et al . (19) . Over 90% of the effluent cells were T cells as tested by their susceptibility to lysis by anti-Thy 1 .2 antiserum in the presence of guinea pig complement .
Removal of Mature T Cells from Bone Marrow. After centrifugation, marrow suspensions were resuspended in a 1 :5 dilution of anti-Thy 1 .2 serum (0 .1 ml undiluted serum/5 X 107 cells) and incubated on ice for 30 min . The cells were then washed twice with at least 20 ml of medium and suspended in a 1 :6 dilution of guinea pig complement (1 .0 ml undiluted complement/3 X 10 8 cells) . After a final incubation in a 37°C water bath for 30 min with occasional mixing, the cells were washed three times with medium and resuspended to the required concentration . Control experiments showed that this procedure lysed >98% of highly purified T cells, i .e . LN cells recirculated from blood to lymph through irradiated intermediate hosts (20) .
LN cells were depleted of T cells by the same two-step procedure except that a higher concentration of anti-Thy 1 .2 serum was used (0.1 ml of undiluted serum/2 X 10 7 cells) .
Antisera. Anti-Thy 1 .2 antiserum was made by injecting AKR/J mice with 2 X 107 C3H/ HeJ thymus cells intraperitoneally at weekly intervals for 12 wk . CBA anti-B6 H-2 alloantiserum was made as described elsewhere (20) .
Mortality Assay for GVHD. Marrow recipients were given 750 rads of 137CS y-irradiation at a dose rate of 106 rads/min. Groups of mice were split into separate cages and kept in a laminar flow room . Neomycin (50 Ntg/1) and Polymyxin B (50 Ftg/ml) were added to the drinking water for 3 wk after irradiation . Plaque-Forming Cell (PFC) Assays . IgM (direct), IgG (indirect), and Ig b -allotype PFC to sheep erythrocytes (SRC) were assayed as described elsewhere (21) . IgG PFC were developed with a polyvalent rabbit anti-mouse Ig antiserum ; Igb PFC were developed with a BALB/c anti-B6 Ig (anti-Igb) anti-allotype serum (21) .
Results
Experimental Design. In all experiments mice received a lethal dose of irradiation (750 rads) . 6-8 h later the mice were injected intravenously with 10 7 marrow cells alone or with the same dose of marrow cells mixed with other cell types . Unless stated otherwise, neither the donors nor the hosts were presensitized . The cell recipients were weighed thrice weekly and examined for signs of GVHD for 80 days or until death . Fig . 1 illustrates mortality occurring in irradiated CBA/J (H-2k ) mice reconstituted with syngeneic CBA/J marrow or with H-2-compatible B lO.BR marrow (B lO.BR and CBA/J express multiple non-MHC antigen differences (vide infra) ; the data are pooled from three experiments involving a total of 30 mice per group.) As expected, only low mortality occurred when syngeneic marrow was injected. Although a few mice died within the first 3-4 wk, there were no deaths after 30 days.
A very different pattern was observed with B l0.BR marrow cells. Ifthese cells were not pretreated with anti-Thy 1 .2 antiserum and complement before injection, lethal chronic GVHD occurred (Fig. 1) . Thus, with transfer of BlO.BR marrow cells treated with control serum (normal AKR serum) and complement, most of the mice died after day 30 and only 20% survived beyond day 80. During this stage the mice showed typical signs of secondary disease before death, e.g. hunched posture, ruffled fur, weight loss, etc . Skin lesions were not seen.
Significantly, neither morbidity nor mortality occurred when B lO.BR marrow cells were treated with anti-Thy 1 .2 serum and complement before injection (Fig. 1) . As with transfer of syngeneic marrow cells, isolated deaths were observed within the 1st mo but there were no deaths nor signs of ill-health after 30 days.
Potentiation of GVH Disease by Adding T Cells to Marrow Inoculum. The above data strongly implied that mature T cells in the marrow inoculum were the cause of secondary disease. The proportion of T cells in B lO.BR marrow appeared to be very low since cytotoxic indices with anti-Thy 1.2 serum and complement were <5% (data not shown) . Accordingly, the addition of even small numbers (<5%) of purified T cells to inocula of anti-Thy 1 .2-serum-treated BlO.BR marrow cells would be expected to restore the incidence of secondary disease.
This prediction is verified by the data shown in Fig Inability of Tolerant T Cells to Cause Lethal GVH Disease. Previous work has shown that T-cell tolerance to host-type MHC alloantigens occurs when parental strain marrow cells are transferred to irradiated H-2-different Fl hybrid mice (22) . To determine whether tolerance to non-H-2 determinants occurs in this situation, lethally irradiated (900 rads) (B6 (H-2b ) X CBA/J)F, mice were reconstituted with 10 7 antiThy 1 .2-serum-treated B10.BR marrow cells. Spleen cells taken from these mice 3 mo later were >95% of donor B10.BR origin, i.e . were resistant to lysis with CBA/J anti-B6 H-2 alloantiserum.
As shown in Fig. 3 a high dose of a mixture of 10 7 marrow cells and 10 7 pooled spleen and LN cells from these chimeras failed to cause mortality in irradiated CBA/ J mice . As expected, the chimera cells were reactive to third-party alloantigens, i .e. they caused rapid mortality in irradiated (C3H/He X BALB/c)F, (H-2 k X H-2d ) mice.
GVHD with other H-2-Compatible Combinations. Results obtained with a variety of other strain combinations fell into three categories (vide infra) (Table I) marrow with anti-Thy 1.2 serum prevented both mortality and morbidity and the addition of normal CBA/J spleen and LN potentiated mortality . GVHD with Spleen and LN Cells but not with Marrow Alone. In most strain combinations tested, untreated marrow cells per se did not cause lethal GVHD. However, with six out of nine of these combinations, marked mortality occurred when the marrow was supplemented with spleen and LN cells of donor origin. A dose of 10' of these cells caused 70-100% mortality and 108 cells produced 100% mortality. With one combination (B10.K -~, CBA/J), studies with nylon-wool-purified LN cells showed that as few as 3 X 105 purified T cells led to >90% mortality (equivalent to 3% T-cell contamination of the marrow) . It is to be noted that with all of these combinations there were at least three minor H antigen differences between the donor and host.
No GVHD. In the remaining three combinations, the addition of even high doses (108) of spleen and LN cells caused only a minimal incidence of GVHD (<35% mortality) . In two of these combinations, only a single minor H antigen difference was involved, i.e. H-9 for B6 --* B10 and H-Y for B 10 female --> B 10 male (in the latter situation even presensitized cells were nonlethal [ Table I] ). In the third combination, i.e. CBA/H-T 6 --+ CBA/J, there were no known minor H differences present . peripheral and mesenteric LN were comparable in cellularity (^-108 cells/mouse) and proportion of T cells (^-50% Thy 1 .2-positive) to LN suspensions from syngeneic chimeras .
The experiment illustrated in Table II " IgG PFC were enhanced with a rabbit anti-mouse Ig antiserum and Igb PFC were enhanced with an anti-Igb allotype antiserum as described in Materials and Methods. # Geometric mean ; number in parenthesis refers to value by which mean is multiplied or divided to give upper and lower limits, respectively, of SE .
roughly comparable to the responses of syngeneic chimeras or nonirradiated mice . Since B lO .B R and CBA/J have different Ig allotypes ( Igb and Iga, respectively), development of anti-SRC PFC with an anti-Igb anti-allotype serum enabled the identity of the PFC to be determined. As shown in Table II , this antiserum developed PFC from B10.BR mice but not from CBA/J mice . In the case of the B10.BR --~' CBA/J combination, it is evident that the numbers of PFC enhanced by the anti-Igb serum were as high (or higher) as in syngeneic BIO.B R --+ BlO.B R chimeras or in normal B10.BR mice. Thus, the vast majority of the PFC were of donor origin . This also appeared to be the case with CBA --* B IO.B R chimeras since these mice contained only small numbers of Igb PFC. Discussion The present data show that in two situations (B lO.BR --* CBA/J and vice versa), transplantation of untreated MHC-identical marrow cells into heavily irradiated allogeneic mice caused a high incidence of lethal chronic GVHD, i.e. mortality occurring between days 20-80 post-transfer. GVHD was not observed when the marrow cells were treated with anti-Thy 1.2 serum and complement before injection. A priori, the protective effect of anti-Thy 1 .2 serum might have reflected activity against (a) T-cell precursors, (b) mature T cells, or (c) both. The first possibility is considered most unlikely because, in contrast to antisera raised in rabbits against mouse brain, there is no evidence that anti-Thy 1 .2 serum prepared in mice has specificity for pre-T cells (26) . The fact that GVHD was restored by the addition of even small numbers of purified LN T cells, but not by adding Thy 1.2-negative cells, strongly implies that mature T cells in marrow were the sole target of the antiserum .
Although marrow cells alone caused mortality in only two situations, it should be emphasized that 100% mortality occurred in six other combinations when spleen and LN cells were added to the marrow inoculum . Before discussing possible reasons for the differing effects of untreated marrow cells, it is first necessary to consider the nature of the antigenic determinants which led to GVHD with spleen and LN cells .
Although the precise identity of the non-MHC antigens evoking GVHD was not established, it seems almost certain that minor H determinants were responsible . Thus, it is evident from Table I that GVHD occurred only with differences at three or more minor H loci. By themselves, Mls determinants did not appear to be involved since GVHD was observed with two Mls-identical combinations (B10.BR -+ CBA/ H-T6 and 129/J --~B10) . Moreover, Mls-incompatibility with identity at minor H loci (CBA/H-T6 CBA/J) gave only minimal evidence of GVHD. Similarly, TLa and Ly antigens were of no apparent importance since GVHD occurred with a TLa-, Ly-identical combination (CBA/J -* C3H/HeJ) .2 However, the data do not exclude the possibility that responses to these antigens or Mls determinants can potentiate reactivity to minor H antigens. Establishing the precise identity of the determinants evoking lethal GVHD will require further work. Double congenic resistant strains differing only at defined minor H loci (29) would be required for this purpose .
Since T cells comprise only a minority population (-2%) of mouse marrow cells (30) , it is perhaps not surprising that lethal GVHD caused by untreated marrow cells alone was the exception rather than the rule. The degree of antigenic disparity between donor and recipient probably contributed to the variable effects of marrow cells per se. Strain variation in the proportion of T cells in marrow is another possibility ; although this notion has not been tested it is of interest that certain rat strains show marked differences in numbers of T cells in marrow (31) . A third possibility is that Ir genes contributed to the incidence of GVHD ; here it is of interest that Ir genes control skin graft rejection (32), T-cell-mediated lympholysis (33, 34) and antibody production (35) to certain minor H determinants. Finally, strain variation in susceptibility to irradiation might have been involved . This was probably z Qa determinahts (which map between the H-2D and Tla loci) deserve consideration since these determinants evoke T-cell-mediated lympholysis (27, 28 and L. Flaherty, personal communication) . Since CBA/J mice express the nonstimulating (b) Qa alleles, the GVHD seen in this strain presumably did not involve responses to Qa determinants .
not an important factor in the present experiments since in several situations the recipients were of the same strain (CBA/J) . However, recently it has become apparent that the constitution of the host is indeed important since it has proved much more difficult to induce GVHD in heterozygous mice than in homozygous mice. Thus, whereas even small doses of B 1O.BR T cells killed CBA/J mice (Table I) , even massive doses (>10) of (B lO.BR X B 10)F, T cells failed to kill MHC-compatible irradiated (B6 X CBA)Fj mice in some experiments (data not shown) .
It is clearly tempting to equate the GVHD seen in the present experiments with the syndrome of secondary disease occurring after marrow transplantation in man. Does it follow therefore that GVHD in man would be abolished by removing T cells from the marrow inoculum? Although this is an obvious prediction it has to be remembered that studies with healthy inbred mice are far removed from the clinical situation where the transplant recipient is generally in poor condition. Moreover, the fact that the recipient is frequently presensitized as the result ofprior blood transfusions implies that a reciprocal HVG reaction is often involved. Finally, GVHD in man differs in certain respects from that seen in mice; for example, skin lesions are rare in mice.
Despite these reservations, the present findings would seem to provide strong support for the rationale for using T-cell-depleted populations as a source of hemopoietic stem cells in man, particularly because human marrow cells contain a much higher proportion of T cells (up to 30% [36] ) than mouse marrow. Until specific anti-T-cell reagents are available in man, fetal liver cells might represent the best alternative (3, 37) . However, although fetal liver cells often give good results, GVHD still occurs on occasions. While in some cases this might reflect contamination with small numbers of post-thymic T cells, an obvious complication with fetal liver transplants is that the HLA haplotype ofthe donor is usually unknown. In this respect, an intriguing alternative explanation is provided by the recent findings of Zinkernagel et al. (38, 39) . These workers have shown that, even with T-cell-depleted marrow cells, allogeneic radiation chimeras in mice usually die after 2-3 mo unless the donor and host share I-region H-2 determinants (identity at the H-2 complex is not necessary since a X b -)-a X c chimeras show good survival) . In essence this study shows that functional T cells develop only in situations where the hemopoietic stem cells share H-2 determinants with the thymus responsible for T-cell differentiation. Without such sharing, the chimeras remain immunoincompetent and most eventually develop the type of runt disease (closely resembling secondary disease) seen in other T-celldeficient states, e.g. in neonatally thymectomized mice. Two key predictions arise from these findings . First, fetal liver cell transplantation in man should fail on a longterm basis unless the donor and host share at least one HLA-D allele (the presumed counterpart of the mouse I region) . Second, transplantation with HLA-D-disparate fetal liver should succeed if the thymus of the donor is also transplanted .
Summary
In two situations, transfer of normal unsensitized bone marrow cells into heavily irradiated H-2-identical allogeneic mice caused a high incidence of lethal chronic graft-versus-host disease (GVHD), i. 
